Trulieve Cannabis (TRLV) EBT (2020 - 2026)

Trulieve Cannabis has reported EBT for 7 years, with the latest figure at -$383.4 million in Q2 2026.

• On a quarterly basis, EBT fell 1085.49% year-over-year to -$383.4 million in Q2 2026; TTM through Jun 2026 was -$325.9 million, a 1073.17% decrease from a year earlier, with the FY2025 full-year figure at $91.5 million, up 114.15% from the prior year.
• EBT was -$383.4 million for Q2 2026 at Trulieve Cannabis, down from $25.2 million in the prior quarter.
• The five-year high for EBT was $38.9 million in Q2 2025, with the low at -$383.4 million in Q2 2026.
• Average EBT over 5 years is -$29.5 million, with a median of $10.9 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: EBT slumped 1265.17% in 2023, then soared 2644.5% in 2024.
• Over 5 years, EBT stood at -$17.6 million in 2022, then jumped by 150.09% to $8.8 million in 2023, then sank by 246.25% to -$12.9 million in 2024, then soared by 122.79% to $2.9 million in 2025, then sank by 13136.25% to -$383.4 million in 2026.
• The last three EBT figures came in at -$383.4 million (Q2 2026), $25.2 million (Q1 2026), and $2.9 million (Q4 2025), per Business Quant data.